Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Integration of transcriptional and mutational data simplifies the stratification of peripheral T-cell lymphoma.

Maura F, Agnelli L, Leongamornlert D, Bolli N, Chan WC, Dodero A, Carniti C, Heavican TB, Pellegrinelli A, Pruneri G, Butler A, Bhosle SG, Chiappella A, Di Rocco A, Zinzani PL, Zaja F, Piva R, Inghirami G, Wang W, Palomero T, Iqbal J, Neri A, Campbell PJ, Corradini P.

Am J Hematol. 2019 Mar 4. doi: 10.1002/ajh.25450. [Epub ahead of print]

PMID:
30829413
2.

The pathological features of angioimmunoblastic T-cell lymphomas with IDH2R172 mutations.

Steinhilber J, Mederake M, Bonzheim I, Serinsöz-Linke E, Müller I, Fallier-Becker P, Lemonnier F, Gaulard P, Fend F, Quintanilla-Martinez L.

Mod Pathol. 2019 Apr 5. doi: 10.1038/s41379-019-0254-4. [Epub ahead of print]

PMID:
30952970
3.

Molecular profiling improves classification and prognostication of nodal peripheral T-cell lymphomas: results of a phase III diagnostic accuracy study.

Piccaluga PP, Fuligni F, De Leo A, Bertuzzi C, Rossi M, Bacci F, Sabattini E, Agostinelli C, Gazzola A, Laginestra MA, Mannu C, Sapienza MR, Hartmann S, Hansmann ML, Piva R, Iqbal J, Chan JC, Weisenburger D, Vose JM, Bellei M, Federico M, Inghirami G, Zinzani PL, Pileri SA.

J Clin Oncol. 2013 Aug 20;31(24):3019-25. doi: 10.1200/JCO.2012.42.5611. Epub 2013 Jul 15.

PMID:
23857971
4.

Overlap at the molecular and immunohistochemical levels between angioimmunoblastic T-cell lymphoma and a subgroup of peripheral T-cell lymphomas without specific morphological features.

Manso R, González-Rincón J, Rodríguez-Justo M, Roncador G, Gómez S, Sánchez-Beato M, Piris MA, Rodríguez-Pinilla SM.

Oncotarget. 2018 Mar 1;9(22):16124-16133. doi: 10.18632/oncotarget.24592. eCollection 2018 Mar 23.

5.

Molecular and Genomic Landscape of Peripheral T-Cell Lymphoma.

Iqbal J, Amador C, McKeithan TW, Chan WC.

Cancer Treat Res. 2019;176:31-68. doi: 10.1007/978-3-319-99716-2_2.

PMID:
30596212
6.

Detection of the G17V RHOA mutation in angioimmunoblastic T-cell lymphoma and related lymphomas using quantitative allele-specific PCR.

Nakamoto-Matsubara R, Sakata-Yanagimoto M, Enami T, Yoshida K, Yanagimoto S, Shiozawa Y, Nanmoku T, Satomi K, Muto H, Obara N, Kato T, Kurita N, Yokoyama Y, Izutsu K, Ota Y, Sanada M, Shimizu S, Komeno T, Sato Y, Ito T, Kitabayashi I, Takeuchi K, Nakamura N, Ogawa S, Chiba S.

PLoS One. 2014 Oct 13;9(10):e109714. doi: 10.1371/journal.pone.0109714. eCollection 2014.

7.

IDH2R172 mutations define a unique subgroup of patients with angioimmunoblastic T-cell lymphoma.

Wang C, McKeithan TW, Gong Q, Zhang W, Bouska A, Rosenwald A, Gascoyne RD, Wu X, Wang J, Muhammad Z, Jiang B, Rohr J, Cannon A, Steidl C, Fu K, Li Y, Hung S, Weisenburger DD, Greiner TC, Smith L, Ott G, Rogan EG, Staudt LM, Vose J, Iqbal J, Chan WC.

Blood. 2015 Oct 8;126(15):1741-52. doi: 10.1182/blood-2015-05-644591. Epub 2015 Aug 12.

8.

Angioimmunoblastic T-cell Lymphomas With the RHOA p.Gly17Val Mutation Have Classic Clinical and Pathologic Features.

Ondrejka SL, Grzywacz B, Bodo J, Makishima H, Polprasert C, Said JW, Przychodzen B, Maciejewski JP, Hsi ED.

Am J Surg Pathol. 2016 Mar;40(3):335-41. doi: 10.1097/PAS.0000000000000555.

PMID:
26574844
9.

Genomic signatures in T-cell lymphoma: How can these improve precision in diagnosis and inform prognosis?

Iqbal J, Wilcox R, Naushad H, Rohr J, Heavican TB, Wang C, Bouska A, Fu K, Chan WC, Vose JM.

Blood Rev. 2016 Mar;30(2):89-100. doi: 10.1016/j.blre.2015.08.003. Epub 2015 Aug 18. Review.

PMID:
26319391
10.

A Survey of Somatic Mutations in 41 Genes in a Cohort of T-Cell Lymphomas Identifies Frequent Mutations in Genes Involved in Epigenetic Modification.

Fernandez-Pol S, Ma L, Joshi RP, Arber DA.

Appl Immunohistochem Mol Morphol. 2018 Apr 7. doi: 10.1097/PAI.0000000000000644. [Epub ahead of print]

PMID:
29629950
11.

The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells.

de Leval L, Rickman DS, Thielen C, Reynies Ad, Huang YL, Delsol G, Lamant L, Leroy K, Brière J, Molina T, Berger F, Gisselbrecht C, Xerri L, Gaulard P.

Blood. 2007 Jun 1;109(11):4952-63. Epub 2007 Feb 6.

12.

Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma.

Heavican TB, Bouska A, Yu J, Lone W, Amador C, Gong Q, Zhang W, Li Y, Dave BJ, Nairismägi ML, Greiner TC, Vose J, Weisenburger DD, Lachel C, Wang C, Fu K, Stevens JM, Lim ST, Ong CK, Gascoyne RD, Missiaglia E, Lemonnier F, Haioun C, Hartmann S, Pedersen MB, Laginestra MA, Wilcox RA, Teh BT, Yoshida N, Ohshima K, Seto M, Rosenwald A, Ott G, Campo E, Rimsza LM, Jaffe ES, Braziel RM, d'Amore F, Inghirami G, Bertoni F, de Leval L, Gaulard P, Staudt LM, McKeithan TW, Pileri S, Chan WC, Iqbal J.

Blood. 2019 Apr 11;133(15):1664-1676. doi: 10.1182/blood-2018-09-872549. Epub 2019 Feb 19.

PMID:
30782609
13.

Pathogenetic and diagnostic significance of microRNA deregulation in peripheral T-cell lymphoma not otherwise specified.

Laginestra MA, Piccaluga PP, Fuligni F, Rossi M, Agostinelli C, Righi S, Sapienza MR, Motta G, Gazzola A, Mannu C, Sabattini E, Bacci F, Tabanelli V, Sacchetti CA, Barrese TZ, Etebari M, Melle F, Clò A, Gibellini D, Tripodo C, Inghirami G, Croce CM, Pileri SA.

Blood Cancer J. 2014 Nov 7;4:259. doi: 10.1038/bcj.2014.78.

14.

Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma.

Iqbal J, Wright G, Wang C, Rosenwald A, Gascoyne RD, Weisenburger DD, Greiner TC, Smith L, Guo S, Wilcox RA, Teh BT, Lim ST, Tan SY, Rimsza LM, Jaffe ES, Campo E, Martinez A, Delabie J, Braziel RM, Cook JR, Tubbs RR, Ott G, Geissinger E, Gaulard P, Piccaluga PP, Pileri SA, Au WY, Nakamura S, Seto M, Berger F, de Leval L, Connors JM, Armitage J, Vose J, Chan WC, Staudt LM; Lymphoma Leukemia Molecular Profiling Project and the International Peripheral T-cell Lymphoma Project.

Blood. 2014 May 8;123(19):2915-23. doi: 10.1182/blood-2013-11-536359. Epub 2014 Mar 14.

15.

Pathobiology and molecular profiling of peripheral T-cell lymphomas.

de Leval L, Gaulard P.

Hematology Am Soc Hematol Educ Program. 2008:272-9. doi: 10.1182/asheducation-2008.1.272.

PMID:
19074096
16.

Molecular genetics of peripheral T-cell lymphomas.

Piccaluga PP, Tabanelli V, Pileri SA.

Int J Hematol. 2014 Mar;99(3):219-26. doi: 10.1007/s12185-014-1522-1. Epub 2014 Jan 31. Review.

PMID:
24481943
17.

Clinical and prognostic differences between ALK-negative anaplastic large cell lymphoma and peripheral T cell lymphoma, not otherwise specified: a single institution experience.

Deng XW, Zhang XM, Wang WH, Wang SL, Jin J, Fang H, Ren H, Liu YP, He XH, Dong M, Song YW, Li YX.

Ann Hematol. 2016 Aug;95(8):1271-80. doi: 10.1007/s00277-016-2696-9. Epub 2016 May 21.

PMID:
27209536
18.

Molecular classification of T-cell lymphomas.

de Leval L, Bisig B, Thielen C, Boniver J, Gaulard P.

Crit Rev Oncol Hematol. 2009 Nov;72(2):125-43. doi: 10.1016/j.critrevonc.2009.01.002. Epub 2009 Feb 23. Review.

PMID:
19233683
19.

Peripheral T-cell lymphoma with follicular T-cell markers.

Rodríguez-Pinilla SM, Atienza L, Murillo C, Pérez-Rodríguez A, Montes-Moreno S, Roncador G, Pérez-Seoane C, Domínguez P, Camacho FI, Piris MA.

Am J Surg Pathol. 2008 Dec;32(12):1787-99. doi: 10.1097/PAS.0b013e31817f123e.

PMID:
18779728
20.

Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters.

Lemonnier F, Couronné L, Parrens M, Jaïs JP, Travert M, Lamant L, Tournillac O, Rousset T, Fabiani B, Cairns RA, Mak T, Bastard C, Bernard OA, de Leval L, Gaulard P.

Blood. 2012 Aug 16;120(7):1466-9. doi: 10.1182/blood-2012-02-408542. Epub 2012 Jul 3.

Supplemental Content

Support Center